These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8325129)

  • 1. Kinetics of filamentation of Escherichia coli induced by different sub-MICs of ceftibuten at different times.
    Braga PC; Piatti G
    Chemotherapy; 1993; 39(4):272-7. PubMed ID: 8325129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sub-minimum inhibitory concentrations of ceftibuten reduce adherence of Escherichia coli to human cells and induces formation of long filaments.
    Braga PC; Piatti G
    Microbiol Immunol; 1993; 37(3):175-9. PubMed ID: 8321147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftibuten: a review of antimicrobial activity, spectrum and other microbiologic features.
    Jones RN
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S77-83. PubMed ID: 7567314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of subinhibitory concentrations of ceftazidime, ciprofloxacin and azithromycin on the morphology and adherence of P-fimbriated escherichia coli.
    Vranes J; Zagar Z; Kurbel S
    J Chemother; 1996 Aug; 8(4):254-60. PubMed ID: 8873829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of subinhibitory concentrations of ceftazidime, ciprofloxacin, and azithromycin on the hemagglutination and adherence of uropathogenic Escherichia coli strains.
    Vranes J
    Chemotherapy; 1996; 42(3):177-85. PubMed ID: 8983884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten.
    Perilli M; Segatore B; Tavio M; Setacci D; Celenza G; De Santis F; Pellegrini C; Rossolini GM; Amicosante G
    J Chemother; 2007 Apr; 19(2):123-6. PubMed ID: 17434819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ceftibuten at sub-inhibitory concentrations in comparison with other antibiotics against respiratory and urinary tract pathogens.
    Maioli E; Marchese A; Roveta S; Cagnacci S; Cavallini F; Cassanelli C; Gualco L; Debbia EA
    J Chemother; 2007 Apr; 19(2):152-60. PubMed ID: 17434823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The post-exposure response of Enterobacteriaceae to ceftibuten.
    MacKenzie FM; Milne KE; Gould IM
    J Antimicrob Chemother; 1999 Jan; 43(1):71-7. PubMed ID: 10381103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third generation oral cephalosporins: comparative in vitro kinetics.
    Speciale A; Blandino G; Nicoletti G
    J Chemother; 1995 May; 7 Suppl 1():9-12. PubMed ID: 8618112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiologic profile of ceftibuten, a new oral cephalosporin.
    Debbia EA; Pesce A; Chiesa M; Ricotta N; Schito GC
    Drugs Exp Clin Res; 1992; 18(4):129-39. PubMed ID: 1451643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sub-Inhibitory Concentration of Piperacillin-Tazobactam May be Related to Virulence Properties of Filamentous Escherichia coli.
    de Andrade JP; de Macêdo Farias L; Ferreira JF; Bruna-Romero O; da Glória de Souza D; de Carvalho MA; dos Santos KV
    Curr Microbiol; 2016 Jan; 72(1):19-28. PubMed ID: 26364189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-exposure effects of cefepime and cefpirome on isogenic Escherichia coli hosts producing SHV-extended-spectrum beta-lactamases.
    Bedenic B; Vranes J
    J Chemother; 2003 Aug; 15(4):342-9. PubMed ID: 12962362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of sub-minimum inhibitory concentrations of cefodizime on the phagocytosis, intracellular killing and oxidative bursts of human polymorphonuclear leukocytes.
    Braga PC; Dal Sasso M; Mancini L; Sala MT
    Chemotherapy; 1999; 45(3):166-74. PubMed ID: 10224338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro effects of ceftibuten on the host defense mechanism.
    Braga PC; Piatti G; Dal Sasso M; Maci S; Blasi F
    Chemotherapy; 1994; 40(1):37-41. PubMed ID: 8306814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells.
    Braga PC; Piatti G
    Chemotherapy; 1993; 39(6):432-7. PubMed ID: 8222872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of antibacterial action of cefprozil, a new cephalosporin, on Escherichia coli, Serratia marcescens and Morganella morganii.
    Nishimoto K; Usui T; Miyake Y; Suginaka H
    Hiroshima J Med Sci; 1991 Mar; 40(1):35-40. PubMed ID: 1864765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of cefepime on opsonophagocytosis of bacteria.
    Raponi G; Keller N; Rozenberg-Arska M; Hoepelman IM; Verhoef J
    Drugs Exp Clin Res; 1989; 15(4):141-4. PubMed ID: 2673713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial filamentation and in vivo efficacy: a comparison of several cephalosporins.
    Ryan DM; Monsey D
    J Antimicrob Chemother; 1981 Jan; 7(1):57-63. PubMed ID: 7009535
    [No Abstract]   [Full Text] [Related]  

  • 19. Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence.
    Braga PC; Sasso MD; Sala MT
    J Antimicrob Chemother; 2000 Jan; 45(1):15-25. PubMed ID: 10629008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic effects of subinhibitory concentrations of rufloxacin on bacterial virulence factors.
    Braga PC; Sala MT; Dal Sasso M
    Antimicrob Agents Chemother; 1999 May; 43(5):1013-9. PubMed ID: 10223908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.